Evaxion scraps tumor vaccine to focus on brain cancer candidate
Fierce Biotech reports Evaxion scrapped its solid tumor vaccine program to focus on a Duke-partnered brain cancer candidate.
Evaxion
Evaxion is a clinical-stage biotechnology company developing AI-driven immunotherapies, including personalized cancer vaccines and vaccines targeting bacterial pathogens, using its proprietary AI platforms PIONEER and EDEN.
Company Info
Sector:AI-driven immunotherapy / Vaccines
Headquarters:Copenhagen, Denmark
Founded:2008
Website:evaxion.ai/